| Dr David Murray Wanicur, MD | |
|
11400 Rockville Pike, Ste. 301, Rockville, MD 20852-3004 | |
| (301) 881-5888 | |
| (301) 881-2945 |
| Full Name | Dr David Murray Wanicur |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 59 Years |
| Location | 11400 Rockville Pike, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598837742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | D13127 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Retina Group Of Washington, Pllc | 5294702692 | 67 |
News Archive
"Treating a yellow fever patient is reliant on having the right diagnosis. This is dependent on having the necessary laboratory capacity to quickly identify the disease," says Dr Pierre Formenty, an expert in haemorrhagic fevers at WHO and Manager of the Emerging Dangerous Pathogens Laboratory Network.
Neuropsychiatric symptoms, but not cognitive impairment, are common in early untreated patients with Parkinson's disease, suggest findings from the multicentre Parkinson's Progression Markers Initiative.
Results from a new study led by Boston Medical Center (BMC) indicate that, when performed appropriately, chemical peels can be a safe treatment option for people with darker skin.
By reprogramming skin cells from Parkinson's disease patients with a known genetic mutation, researchers at the Salk Institute for Biological Studies have identified damage to neural stem cells as a powerful player in the disease.
› Verified 9 days ago
| Entity Name | Ladas Eye Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902837149 PECOS PAC ID: 6406822584 Enrollment ID: O20040909000655 |
News Archive
"Treating a yellow fever patient is reliant on having the right diagnosis. This is dependent on having the necessary laboratory capacity to quickly identify the disease," says Dr Pierre Formenty, an expert in haemorrhagic fevers at WHO and Manager of the Emerging Dangerous Pathogens Laboratory Network.
Neuropsychiatric symptoms, but not cognitive impairment, are common in early untreated patients with Parkinson's disease, suggest findings from the multicentre Parkinson's Progression Markers Initiative.
Results from a new study led by Boston Medical Center (BMC) indicate that, when performed appropriately, chemical peels can be a safe treatment option for people with darker skin.
By reprogramming skin cells from Parkinson's disease patients with a known genetic mutation, researchers at the Salk Institute for Biological Studies have identified damage to neural stem cells as a powerful player in the disease.
› Verified 9 days ago
| Entity Name | The Retina Group Of Washington, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225001654 PECOS PAC ID: 5294702692 Enrollment ID: O20040915000226 |
News Archive
"Treating a yellow fever patient is reliant on having the right diagnosis. This is dependent on having the necessary laboratory capacity to quickly identify the disease," says Dr Pierre Formenty, an expert in haemorrhagic fevers at WHO and Manager of the Emerging Dangerous Pathogens Laboratory Network.
Neuropsychiatric symptoms, but not cognitive impairment, are common in early untreated patients with Parkinson's disease, suggest findings from the multicentre Parkinson's Progression Markers Initiative.
Results from a new study led by Boston Medical Center (BMC) indicate that, when performed appropriately, chemical peels can be a safe treatment option for people with darker skin.
By reprogramming skin cells from Parkinson's disease patients with a known genetic mutation, researchers at the Salk Institute for Biological Studies have identified damage to neural stem cells as a powerful player in the disease.
› Verified 9 days ago
| Entity Name | Central Maryland Eye Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003906983 PECOS PAC ID: 8022028059 Enrollment ID: O20070212000272 |
News Archive
"Treating a yellow fever patient is reliant on having the right diagnosis. This is dependent on having the necessary laboratory capacity to quickly identify the disease," says Dr Pierre Formenty, an expert in haemorrhagic fevers at WHO and Manager of the Emerging Dangerous Pathogens Laboratory Network.
Neuropsychiatric symptoms, but not cognitive impairment, are common in early untreated patients with Parkinson's disease, suggest findings from the multicentre Parkinson's Progression Markers Initiative.
Results from a new study led by Boston Medical Center (BMC) indicate that, when performed appropriately, chemical peels can be a safe treatment option for people with darker skin.
By reprogramming skin cells from Parkinson's disease patients with a known genetic mutation, researchers at the Salk Institute for Biological Studies have identified damage to neural stem cells as a powerful player in the disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Murray Wanicur, MD 11400 Rockville Pike, Ste. 301, Rockville, MD 20852-3004 Ph: (301) 881-5888 | Dr David Murray Wanicur, MD 11400 Rockville Pike, Ste. 301, Rockville, MD 20852-3004 Ph: (301) 881-5888 |
News Archive
"Treating a yellow fever patient is reliant on having the right diagnosis. This is dependent on having the necessary laboratory capacity to quickly identify the disease," says Dr Pierre Formenty, an expert in haemorrhagic fevers at WHO and Manager of the Emerging Dangerous Pathogens Laboratory Network.
Neuropsychiatric symptoms, but not cognitive impairment, are common in early untreated patients with Parkinson's disease, suggest findings from the multicentre Parkinson's Progression Markers Initiative.
Results from a new study led by Boston Medical Center (BMC) indicate that, when performed appropriately, chemical peels can be a safe treatment option for people with darker skin.
By reprogramming skin cells from Parkinson's disease patients with a known genetic mutation, researchers at the Salk Institute for Biological Studies have identified damage to neural stem cells as a powerful player in the disease.
› Verified 9 days ago
Dr. Mark Hendrix, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3204 Tower Oaks Blvd, Suite 300, Rockville, MD 20852 Phone: 301-231-5088 | |
Dr. Barbara Ann Gots, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2301 Research Blvd, Suite 210, Rockville, MD 20850 Phone: 301-519-0300 Fax: 301-519-1307 | |
Dr. Stacy Jung Bang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3204 Tower Oaks Blvd Ste 300, Rockville, MD 20852 Phone: 301-231-5088 Fax: 301-231-5254 | |
Dr. Marshall Phillip Keys, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 121 Congressional Ln, Ste 601, Rockville, MD 20852 Phone: 301-231-7070 Fax: 301-231-7073 | |
Dr. Natasha Herz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 611 Rockville Pike Ste 120, Rockville, MD 20852 Phone: 240-328-6812 Fax: 240-499-8291 | |
Dr. Alisa Kim, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2403 Research Blvd Ste 102, Suite 102, Rockville, MD 20850 Phone: 240-232-2020 Fax: 240-232-2016 | |
Dr. Jenifer Ann Aventuro, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 15235 Shady Grove Rd Ste 101, Rockville, MD 20850 Phone: 301-330-1366 |